Ada Wong is the executive director, intellectual property, at Revolution Medicines, Inc. Having served in-house and in private practice, Ada has over 21 years of experience providing IP counseling and managing portfolios at different stages of the product development continuum. Ada spent years in the pharma industry (Jazz Pharmaceuticals, JnJ, Salix), devising global IP strategy for marketed drugs and clinical-phase products, and advising startups at the intersection of AI and healthcare. She has a JD from Santa Clara University, an MS in biotechnology from the Johns Hopkins University, and a B.S. in molecular cell biology from U.C. Berkeley.